Position in NAMS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$1,079,429
+$144,066 QoQ
Shares Held
31,851
+9.0% QoQ
Ownership
0.027%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#111
of 197 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NAMS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026STIFEL FINANCIAL CORP holds $537,727,692 across 104 Biotechnology names. NAMS ranks #43 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BHVN |
Biohaven Ltd.
|
9,941,165 | $147,924,534 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
162,151 | $80,545,262 | |
| 3 | MANE |
Veradermics, Inc
|
294,117 | $36,158,743 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
139,491 | $33,613,146 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
46,378 | $28,918,535 | |
| 6 | OMER |
Omeros Corp
|
1,836,925 | $17,469,155 | |
| 7 | NTLA |
Intellia Therapeutics, Inc.
|
1,014,387 | $17,163,427 | |
| 8 | IONS |
Ionis Pharmaceuticals Inc
|
202,983 | $16,094,521 |
All Filings in NAMS
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,079,429 | 31,851 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $935,363 | 29,221 | Shares | Defined | 2026-05-12 | |
| No filing history on record for this holder in this stock. | ||||||